Charles River Laboratories (CRL) Tops Q4 EPS by 4c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $185.00 --0%
EPS Growth %: -12.5%
Financial Fact:
Net income: 38.03M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -12.5%
Financial Fact:
Net income: 38.03M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $2.39, $0.04 better than the analyst estimate of $2.35. Revenue for the quarter came in at $994.2 million versus the consensus estimate of $987.2 million.
GUIDANCE:
Charles River Laboratories sees FY2026 EPS of $10.70-$11.20, versus the consensus of $10.89.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
- Vail Resorts (MTN) call put ratio 1 call to 1 put amid price movement
- Carnival Corp. (CCL) call put ratio 1.2 calls to 1 put into quarter results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
